AI assistant
LEMAITRE VASCULAR INC — Director's Dealing 2019
Sep 9, 2019
31708_dirs_2019-09-09_c498e43b-0bd4-4978-a587-b9795372e6c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2019-09-05
Reporting Person: Pellegrino Joseph P JR (Director, Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-09-05 | Dividend Equivalent Rights | $ | A | 5 | Acquired | Common Stock (5) | Direct | |
| 2019-09-05 | Dividend Equivalent Rights | $ | A | 4 | Acquired | Common Stock (4) | Direct | |
| 2019-09-05 | Dividend Equivalent Rights | $ | A | 7 | Acquired | Common Stock (7) | Direct |
Footnotes
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.